St Jude Medical
STJ
STJ was delisted on the 4th of January, 2017.
570 hedge funds and large institutions have $19.8B invested in St Jude Medical in 2016 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 183 increasing their positions, 243 reducing their positions, and 84 closing their positions.
2% more funds holding in top 10
Funds holding in top 10: 42 → 43 (+1)
4% more capital invested
Capital invested by funds: $19B → $19.8B (+$812M)
7% less funds holding
Funds holding: 615 → 570 (-45)
25% less repeat investments, than reductions
Existing positions increased: 183 | Existing positions reduced: 243
49% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 84
73% less call options, than puts
Call options by funds: $97.9M | Put options by funds: $358M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$366M |
| 2 |
TP
Third Point
New York
|
+$210M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$192M |
| 4 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
+$182M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$119M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sanders Capital
West Palm Beach,
Florida
|
-$384M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$201M |
| 3 |
EA
Emerald Acquisition
Seattle,
Washington
|
-$95M |
| 4 |
Barclays
London,
United Kingdom
|
-$75.3M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$75M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TDC
651
Thompson Davis & Co
Richmond,
Virginia
| – | -$6K | -82 | Closed |
|
|
WP
652
WealthPLAN Partners
Omaha,
Nebraska
| – | -$5 | -59 | Closed |
|
|
FAM
653
Fred Alger Management
New York
| – | -$4K | -56 | Closed |
|
654
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | -$4.36K | -54 | -90% |
|
STJ Hedge Fund Activity: Q3 2016 in Review
570 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q3 2016, worth a combined $19.8B — up 4.3% from $19B a quarter earlier.
Sellers outnumbered buyers: 84 funds closed out of STJ and 43 opened new positions — a net loss of 41 holders — while 243 trimmed existing stakes and 183 added.
The largest buyer was Farallon Capital Management, adding an estimated $366M. The largest seller was Sanders Capital, exiting entirely with an estimated $384M sold.
- 570 institutional investors held St Jude Medical (STJ) as of Q3 2016, down from 615 in Q2 2016.
- Funds reported $19.8B of St Jude Medical stock for Q3 2016, up 4.3% quarter-over-quarter.
- 43 funds opened new St Jude Medical positions in Q3 2016 and 84 closed out, a net change of -41 holders.
- The largest St Jude Medical buyer in Q3 2016 was Farallon Capital Management, an estimated $366M added.
- The largest St Jude Medical seller in Q3 2016 was Sanders Capital, an estimated $384M sold.
Based on aggregated 13F filings for Q3 2016.